Clinical Trial Update: Treatment of Cabotamig (ARB202) in Advanced Gastrointestinal Cancer Patients [Phase 1]

View source ↗

Summary

Phase 1 trial of Cabotamig (ARB202) in advanced gastrointestinal cancers has completed; no specific efficacy results are provided in the document.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma
• Colorectal Adenocarcinoma
• Esophageal Adenocarcinoma
• Gastric Cancer
• Gastroesophageal Junction Cancer
• Gastrointestinal Neuroendocrine Tumor
• Hepatocellular Carcinoma
• Pancreatic Cancer

Drugs mentioned

• Cabotamig (ARB202)

Snippet

Sponsor: Arbele Pty Ltd | Conditions: Gastrointestinal Cancer, Cholangiocarcinoma | Phase 1 | Status: COMPLETED